R. Matthew Neff, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 1,410 shares at $1.98 ($3K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Open-market purchase of $3k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| NOTV | SELL | 2025-10-03 | $3K | — | Filing → |
| NOTV | SELL | 2025-09-04 | $3K | — | Filing → |
| NOTV | SELL | 2025-08-04 | $4K | — | Filing → |